CN1364164A - 4-氰基-2-氨基甲基噻唑的制备方法 - Google Patents
4-氰基-2-氨基甲基噻唑的制备方法 Download PDFInfo
- Publication number
- CN1364164A CN1364164A CN00810619A CN00810619A CN1364164A CN 1364164 A CN1364164 A CN 1364164A CN 00810619 A CN00810619 A CN 00810619A CN 00810619 A CN00810619 A CN 00810619A CN 1364164 A CN1364164 A CN 1364164A
- Authority
- CN
- China
- Prior art keywords
- formula
- thiazole
- represent
- side chain
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title abstract description 6
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 125000005219 aminonitrile group Chemical group 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 26
- -1 cysteine ester Chemical class 0.000 claims description 17
- IJVLVRYLIMQVDD-UHFFFAOYSA-N 1,3-thiazole-2-carboxylic acid Chemical compound OC(=O)C1=NC=CS1 IJVLVRYLIMQVDD-UHFFFAOYSA-N 0.000 claims description 13
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 claims description 11
- 150000001408 amides Chemical class 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- XPDWGBQVDMORPB-UHFFFAOYSA-N Fluoroform Chemical compound FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 9
- 235000018417 cysteine Nutrition 0.000 claims description 9
- 239000012442 inert solvent Substances 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 230000000903 blocking effect Effects 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 5
- 125000003368 amide group Chemical group 0.000 claims description 5
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000013067 intermediate product Substances 0.000 claims description 4
- 238000005336 cracking Methods 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 abstract description 5
- REMBJHSATGMNMU-UHFFFAOYSA-N 2-amino-5-methyl-1,3-thiazole-4-carbonitrile Chemical compound CC=1SC(N)=NC=1C#N REMBJHSATGMNMU-UHFFFAOYSA-N 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000003643 water by type Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 238000006356 dehydrogenation reaction Methods 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 238000010189 synthetic method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 5
- 150000003556 thioamides Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VNZMUHKDSSZWAN-UHFFFAOYSA-N Cl.CN(C(=O)N)N=O Chemical compound Cl.CN(C(=O)N)N=O VNZMUHKDSSZWAN-UHFFFAOYSA-N 0.000 description 3
- 229940122388 Thrombin inhibitor Drugs 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003407 synthetizing effect Effects 0.000 description 3
- 239000003868 thrombin inhibitor Substances 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000008361 aminoacetonitriles Chemical class 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- VQFAIAKCILWQPZ-UHFFFAOYSA-N bromoacetone Chemical compound CC(=O)CBr VQFAIAKCILWQPZ-UHFFFAOYSA-N 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- 150000001944 cysteine derivatives Chemical class 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N dimethylpyridine Natural products CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- 238000010644 ester aminolysis reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JOZSYOPADROCMP-UHFFFAOYSA-N 1,3-thiazol-2-ylmethanamine Chemical compound NCC1=NC=CS1 JOZSYOPADROCMP-UHFFFAOYSA-N 0.000 description 1
- PNAFRZGWUVQUKH-UHFFFAOYSA-N 1,3-thiazole-4-carbonitrile Chemical class N#CC1=CSC=N1 PNAFRZGWUVQUKH-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YOYAIZYFCNQIRF-UHFFFAOYSA-N 2,6-dichlorobenzonitrile Chemical compound ClC1=CC=CC(Cl)=C1C#N YOYAIZYFCNQIRF-UHFFFAOYSA-N 0.000 description 1
- GPBICYITRWEKAX-UHFFFAOYSA-N 2-aminosulfanylethanol Chemical class NSCCO GPBICYITRWEKAX-UHFFFAOYSA-N 0.000 description 1
- ZTVIKZXZYLEVOL-DGKWVBSXSA-N 2-hydroxy-2-phenylacetic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester Chemical group C([C@H]1CC[C@@H](C2)N1C)C2OC(=O)C(O)C1=CC=CC=C1 ZTVIKZXZYLEVOL-DGKWVBSXSA-N 0.000 description 1
- CCNOBBUJPWLYMB-UHFFFAOYSA-N 5-amino-2-methyl-1,3-thiazole-4-carbonitrile Chemical compound CC1=NC(C#N)=C(N)S1 CCNOBBUJPWLYMB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010037003 Buserelin Proteins 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 238000005677 Lawesson carbonylation reaction Methods 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- XNNQFQFUQLJSQT-UHFFFAOYSA-N bromo(trichloro)methane Chemical class ClC(Cl)(Cl)Br XNNQFQFUQLJSQT-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- DAVKOMBJLJVVLC-UHFFFAOYSA-N chloroform;hydrobromide Chemical compound Br.ClC(Cl)Cl DAVKOMBJLJVVLC-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003557 thiazoles Chemical class 0.000 description 1
- 150000003548 thiazolidines Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19934066A DE19934066A1 (de) | 1999-07-23 | 1999-07-23 | Verfahren zur Herstellung von 4-Cyano-2-aminomethylthiazol |
DE19934066.8 | 1999-07-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1364164A true CN1364164A (zh) | 2002-08-14 |
Family
ID=7915457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00810619A Pending CN1364164A (zh) | 1999-07-23 | 2000-07-11 | 4-氰基-2-氨基甲基噻唑的制备方法 |
Country Status (21)
Country | Link |
---|---|
US (1) | US6639081B1 (zh) |
EP (1) | EP1196402A1 (zh) |
JP (1) | JP4027093B2 (zh) |
KR (1) | KR20020028214A (zh) |
CN (1) | CN1364164A (zh) |
AU (1) | AU6691600A (zh) |
BG (1) | BG106332A (zh) |
BR (1) | BR0012710A (zh) |
CA (1) | CA2380169C (zh) |
DE (1) | DE19934066A1 (zh) |
HK (1) | HK1047931A1 (zh) |
HU (1) | HUP0201977A2 (zh) |
IL (2) | IL147804A0 (zh) |
MX (1) | MXPA02000773A (zh) |
NO (1) | NO20020328L (zh) |
NZ (1) | NZ516807A (zh) |
PL (1) | PL355111A1 (zh) |
SK (1) | SK1062002A3 (zh) |
TR (1) | TR200200181T2 (zh) |
WO (1) | WO2001007426A1 (zh) |
ZA (1) | ZA200200459B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19933861A1 (de) * | 1999-07-23 | 2001-01-25 | Basf Ag | Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol |
US20050027128A1 (en) * | 2003-07-30 | 2005-02-03 | Robbins Timothy A. | Substituted thiazoles |
WO2012007426A1 (en) | 2010-07-13 | 2012-01-19 | Basf Se | Azoline substituted isoxazoline benzamide compounds for combating animal pests |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000047461A (ko) * | 1998-12-29 | 2000-07-25 | 성재갑 | 트롬빈 억제제 |
DE19933861A1 (de) * | 1999-07-23 | 2001-01-25 | Basf Ag | Verfahren zur Herstellung von 2-Aminomethyl-4-cyano-thiazol |
-
1999
- 1999-07-23 DE DE19934066A patent/DE19934066A1/de not_active Withdrawn
-
2000
- 2000-07-11 AU AU66916/00A patent/AU6691600A/en not_active Abandoned
- 2000-07-11 BR BR0012710-8A patent/BR0012710A/pt not_active IP Right Cessation
- 2000-07-11 EP EP00954468A patent/EP1196402A1/de not_active Withdrawn
- 2000-07-11 CN CN00810619A patent/CN1364164A/zh active Pending
- 2000-07-11 HU HU0201977A patent/HUP0201977A2/hu unknown
- 2000-07-11 US US10/031,703 patent/US6639081B1/en not_active Expired - Lifetime
- 2000-07-11 SK SK106-2002A patent/SK1062002A3/sk not_active Application Discontinuation
- 2000-07-11 PL PL00355111A patent/PL355111A1/xx not_active Application Discontinuation
- 2000-07-11 MX MXPA02000773A patent/MXPA02000773A/es unknown
- 2000-07-11 IL IL14780400A patent/IL147804A0/xx unknown
- 2000-07-11 CA CA002380169A patent/CA2380169C/en not_active Expired - Fee Related
- 2000-07-11 KR KR1020027000960A patent/KR20020028214A/ko not_active Application Discontinuation
- 2000-07-11 WO PCT/EP2000/006563 patent/WO2001007426A1/de active IP Right Grant
- 2000-07-11 NZ NZ51680700A patent/NZ516807A/xx unknown
- 2000-07-11 JP JP2001512511A patent/JP4027093B2/ja not_active Expired - Fee Related
- 2000-07-11 TR TR2002/00181T patent/TR200200181T2/xx unknown
-
2002
- 2002-01-18 ZA ZA200200459A patent/ZA200200459B/en unknown
- 2002-01-21 BG BG106332A patent/BG106332A/bg unknown
- 2002-01-22 NO NO20020328A patent/NO20020328L/no unknown
- 2002-01-23 IL IL147804A patent/IL147804A/en not_active IP Right Cessation
-
2003
- 2003-01-02 HK HK03100002.3A patent/HK1047931A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DE19934066A1 (de) | 2001-01-25 |
CA2380169C (en) | 2007-01-09 |
IL147804A (en) | 2008-11-03 |
CA2380169A1 (en) | 2001-02-01 |
AU6691600A (en) | 2001-02-13 |
ZA200200459B (en) | 2004-05-26 |
TR200200181T2 (tr) | 2002-08-21 |
KR20020028214A (ko) | 2002-04-16 |
PL355111A1 (en) | 2004-04-05 |
SK1062002A3 (en) | 2002-07-02 |
MXPA02000773A (es) | 2002-07-22 |
WO2001007426A1 (de) | 2001-02-01 |
BG106332A (bg) | 2002-08-30 |
HUP0201977A2 (en) | 2002-09-28 |
NO20020328L (no) | 2002-01-31 |
NO20020328D0 (no) | 2002-01-22 |
BR0012710A (pt) | 2002-04-09 |
IL147804A0 (en) | 2002-08-14 |
HK1047931A1 (zh) | 2003-03-14 |
JP2003532624A (ja) | 2003-11-05 |
NZ516807A (en) | 2004-12-24 |
US6639081B1 (en) | 2003-10-28 |
EP1196402A1 (de) | 2002-04-17 |
JP4027093B2 (ja) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2509299A1 (fr) | Antibiotiques a noyau b-lactame, et procede pour les preparer | |
MX2008013711A (es) | Actividad inhibitoria de absorcion de colesterol que posee derivados de difenilazetidinona. | |
EP0462009B1 (fr) | Céphalosporines comportant en position 3 un radical propényle substitué par un ammonium quaternaire, leur procédé de préparation, leur application comme médicaments, les compositions les renfermant et les intermédiaires obtenus | |
US7148355B2 (en) | Process for the preparation of repaglinide | |
JPS6321677B2 (zh) | ||
CN1364164A (zh) | 4-氰基-2-氨基甲基噻唑的制备方法 | |
JP3165698B2 (ja) | チオアシル化試薬および中間体,チオペプチド,およびこれらの調製および使用法 | |
CN1278253A (zh) | 取代的烷基胺或其盐的生产方法 | |
EP0581220A2 (en) | Process for preparing cephalosporin intermediates | |
JPH064641B2 (ja) | セフアロスポリン誘導体の製造方法 | |
EP1529778A1 (en) | Production method of pyrimidine derivative, intermediate therefor | |
CN1364163A (zh) | 2-氨基甲基-4-氰基-噻唑的制备方法 | |
CN1915998A (zh) | β-内酰胺中间体结晶 | |
KR20050035178A (ko) | 알킬- 또는 아릴-술포네이트를 경유한 세픽심의 제조방법 | |
Cabarrocas et al. | A new approach toward the stereoselective synthesis of novel quinolyl glycines: synthesis of the enantiomerically pure quinolyl-β-amino alcohol precursors | |
JP3811885B2 (ja) | 4−チアゾリルメチル誘導体の製造方法 | |
CN1309713C (zh) | 制备头孢菌素侧链的方法 | |
CN1315841C (zh) | 制备氯甲基头孢烯衍生物的改进方法 | |
CN86107742A (zh) | 季胺化的2-位具有杂硫烷硫取代基的碳代氰霉烯 | |
CN1023322C (zh) | 羧基链烯酰胺基头孢菌素类化合物的制备方法 | |
NZ210718A (en) | The preparation of azetidinones | |
Barton et al. | Asymmetric synthesis of 1, 3, 4-trisubstituted and 3, 4-disubstituted 2-azetidinones: strategy based on use of D-glucosamine as a chiral auxiliary in the Staudinger reaction | |
WO2001016117A1 (fr) | Procedes de preparation de derives d'acide oxo-oxazoline ou alloamino | |
CN104411708B (zh) | 制备对映异构体富集的草酰胺类的方法 | |
CN1048856A (zh) | 头孢菌素衍生物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: AVECIA BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BASF AKTIENGESELLCHAFT Effective date: 20030807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20030807 Address after: Wiesbaden Applicant after: Ebert GmbH & Co. KG Address before: Ludwigshafen, Germany Applicant before: Basf AG |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1047931 Country of ref document: HK |